Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Looks To Capitol Hill For New Authority For Globalization Plan

This article was originally published in PharmAsia News

Executive Summary

Legislative fixes are required for U.S. FDA to implement its long-term strategy to use a coalition of regulators to secure the world drug supply chain, but the agency says it will not let that stop it from implementing its Pathway to Global Product Safety and Quality plan

You may also be interested in...



Global GMPs: How Much Faith Will U.S. FDA Put In Private Third-Party Audits?

Private and third-party audits may not replace U.S. FDA's typical inspection duties, but could help direct the agency to problematic facilities and relieve some of the inspection burden on those that already are compliant

Global GMPs: How Much Faith Will U.S. FDA Put In Private Third-Party Audits?

Private and third-party audits may not replace U.S. FDA's typical inspection duties, but could help direct the agency to problematic facilities and relieve some of the inspection burden on those that already are compliant

U.S. FDA Foreign Inspections User Fee Program Getting Push From Congress

The pharmaceutical industry is facing an increasingly aggressive push to create user fees for manufacturing inspections

Related Content

UsernamePublicRestriction

Register

OM003387

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel